Extracellular signal-regulated kinase (ERK) activation is required for porcine epidemic diarrhea virus replication  by Kim, Youngnam & Lee, Changhee
Extracellular signal-regulated kinase (ERK) activation is required
for porcine epidemic diarrhea virus replication
Youngnam Kim, Changhee Lee n
Animal Virology Laboratory, School of Life Sciences, BK21 plus KNU Creative BioResearch Group, Kyungpook National University, Daegu 702-701,
Republic of Korea
a r t i c l e i n f o
Article history:
Received 23 April 2015
Returned to author for revisions
28 May 2015
Accepted 4 June 2015
Available online 23 June 2015
Keywords:
PEDV
ERK1/2
Elk-1
Signal transduction
Viral replication
a b s t r a c t
Porcine epidemic diarrhea virus (PEDV) is a highly enteropathogenic coronavirus of swine that causes
acute enteritis with high mortality in nursery piglets. To date, the cellular factors involved in PEDV
replication have not been well deﬁned. The extracellular signal-regulated kinase (ERK) that serves as a
critical component of cellular signal transduction pathways to modulate a variety of cellular functions
has been shown to regulate several viral infections. In the present study, we found that PEDV activates
ERK1/2 early in infection independently of viral replication. The PEDV-induced ERK1/2 activation
resulted in the phosphorylation of its downstream substrate Elk-1 in infected cells. Treatment with ERK
inhibitors or ERK1/2 knockdown signiﬁcantly suppressed viral progeny production. Inhibition of ERK
activation also diminished viral protein expression and genomic and subgenomic RNA transcription.
These ﬁndings indicate that the ERK signaling pathway plays an important role in the PEDV life cycle and
beneﬁcially contributes to viral infection.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Porcine epidemic diarrhea (PED) is an emerging and important
swine disease that causes acute enteritis with high mortality in
piglets (Debouck and Pensaert, 1980; Pijpers et al., 1993; Saif et al.,
2012). PED is characterized by severe villous atrophy in the small
intestine, which is more serious in newborn pigs than in older
pigs, resulting in malabsorptive watery diarrhea followed by fatal
dehydration in piglets (Madson et al., 2014; Saif et al., 2012,
Shibata et al., 2000). The associated mortality rates vary depend-
ing on age likely due to age-dependent disease severity and
generally approach 90–100% in 1- to 3-day-old neonatal piglets
(Saif et al., 2012). The disease was ﬁrst observed in the United
Kingdom in 1971 and then spread to multiple swine-producing
European countries (Chasey and Cartwright, 1978; Oldham, 1972;
Pensaert et al., 1981). In Asia, PED epidemics ﬁrst occurred in 1982
and since then, PED remains a major concern in Asian countries,
particularly in China and South Korea (Chen et al., 2008; Kweon
et al., 1993; Li et al., 2012; Puranaveja et al., 2009; Sun et al., 2012;
Takahashi et al., 1983). During 2013 and 2014, a severe large-scale
PED epizootic emerged in the United States and re-emerged in
South Korea, Taiwan, and Japan, which led to tremendous ﬁnancial
losses in the pork industries in these countries (Lee and Lee, 2014;
Lee et al., 2014a, 2014b; Lin et al., 2014; Mole, 2013; Stevenson
et al., 2013).
The etiological agent of PED, the PED virus (PEDV), was identiﬁed
in 1978 as a coronavirus, which is a member of the genus Alphacor-
onavirus within the family Coronaviridae of the order Nidovirales
(Pensaert and de Bouck, 1978; Saif et al., 2012). PEDV is a large,
enveloped virus possessing a single-stranded positive-sense RNA
genome, approximately 28 kb long, with a 50 cap and a 30 poly-
adenylated tail (Pensaert and de Bouck, 1978; Saif et al., 2012). The
PEDV genome is composed of a 50 untranslated region (UTR), at least
7 open reading frames (ORF1a, ORF1b, and ORF2 through 6), and a 30
UTR (Kocherhans et al., 2001). The two large ORF1a and 1b compris-
ing the 50 two-thirds of the genome encode non-structural proteins
(nsps). The remaining ORFs in the 30 terminal region code for four
major structural proteins, the 150–220 kDa glycosylated spike
(S) protein, 20–30 kDa membrane (M) protein, 7 kDa envelop
(E) protein, and 58 kDa nucleocapsid (N) protein (Duarte et al.,
1994; Saif et al., 2012). PEDV infection is initiated by binding of the
viral S protein to the receptor on host cells, and the viral genome is
released into the cytoplasm after the viral entry process. As positive-
strand RNA viruses, the PEDV genome functions as an mRNA for the
synthesis of viral proteins. Translation initially occurs from ORF1a and
ORF1b, yielding the la and lab replicase polyproteins, with the latter
produced by a 1 ribosomal frame shift. These polyproteins are
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subsequently cleaved into functional 16 nsps including the viral RNA-
dependent RNA polymerase (RdRp). The RdRp-containing replication
complex in turn mediates viral genomic RNA synthesis and subge-
nomic (sg) mRNA transcription, eventually producing a nested set of
30 co-terminal sg mRNAs that are individually translated to structural
proteins (Lai et al., 2007; Saif et al., 2012). A recent report has shown
that PEDV induces caspase-independent apoptosis through the acti-
vation of mitochondrial apoptosis-inducing factor (AIF) to facilitate
viral replication and pathogenesis (Kim and Lee, 2014). However,
whether other cellular factors or mechanisms may also regulate PEDV
infection is still unknown.
The mitogen-activated protein kinase (MAPK) cascade pathways
are central building blocks in the intracellular signaling network. As
the global cellular regulators in response to various extracellular
stimuli, the MAPK pathways transmit signals to diverse intracellular
targets and exquisitely control numerous cellular activities. The
extracellular signaling-regulated kinase (ERK) signaling pathway is
one of the three MAPK cascades that play important roles in the
regulation of various cellular processes (Garrington and Johnson,
1999; Roux and Blenis, 2004). Activation of the ERK pathway includes
three signal cascades, Raf, MEK1/2, and ERK1/2. Upon stimulation,
the Raf/MEK/ERK cascade is initiated by receptor tyrosine kinases
that signal through the small GTP-binding protein Ras. This event
results in Raf activation that binds to and phosphorylates the dual
speciﬁcity kinases MEK1/2, which in turn activates ERK1/2 by
phosphorylation. The activated ERK1/2 ﬁnally translocates into the
nucleus and phosphorylates numerous downstream substrates
including transcription factors regulating transcription for a large
number of genes. Therefore, the ERK pathway modulates a wide
range of important cellular functions, such as cell proliferation,
differentiation, survival and apoptosis (Roux and Blenis, 2004;
Shaul and Seger, 2007). Since viruses are obligate intracellular
parasites, they may regulate such functions to beneﬁt their own
multiplication in host cells by manipulating the ERK signaling path-
way. In fact, several viruses have been shown to exploit the host ERK
signaling pathway for optimal viral replication and gene expression
(Cai et al., 2007; Lee and Lee, 2010; Lim et al., 2005; Marjuki et al.,
2006; Moser and Schultz-Cherry, 2008; Schümann and Dobbelstein,
2006; Wang et al., 2006; Wei and Liu, 2009; Zampieri et al., 2007).
However, the role of the ERK signaling pathway in PEDV replication
has not been determined.
In the present study, we tried to examine whether PEDV infection
activates the ERK signaling pathway in cultured cells and ERK
activation is involved in PEDV replication. It was found that PEDV
induces early strong and transient activation of ERK1/2 that is
independent of maximal viral gene expression. Furthermore, UV-
inactivated virus was sufﬁcient to trigger ERK1/2 activation, indicat-
ing the absence of a critical action of viral replication for its
phosphorylation. PEDV production was signiﬁcantly impaired by
MEK inhibitors and ERK1/2-speciﬁc siRNA. Further experiments
revealed that independent treatment with each MEK inhibitor
resulted in the distinct reduction of viral RNA synthesis and viral
protein translation but did not affect viral entry. In addition, inhibi-
tion of ERK activation had no effect on PEDV-induced apoptotic cell
death. Together, our data demonstrate a pivotal role for the ERK
signaling pathway in a post-attachment stage of the PEDV life cycle.
Results
PEDV activates ERK1/2
In order to investigate the effect of PEDV on the ERK1/2
signaling cascade, the kinetics of ERK1/2 phosphorylation was
monitored in Vero cells infected with PEDV at an MOI of 1 at
different times postinfection byWestern blot analysis. As shown in
Fig. 1 A, only small amounts of activated ERK1/2 were detected in
mock-infected Vero cells as a negative control. This was consid-
ered the background level of phosphorylated ERK1/2 (pERK1/2),
possibly in response to the components of the media. In contrast,
PEDV infection signiﬁcantly stimulated ERK1/2 activity by 6 h
postinfection (hpi) that was most markedly induced at 12 hpi
and then dramatically decreased at 24 hpi, returning to the base-
line level thereafter. In addition, the activation proﬁle of ERK1/2
was comparably observed in cells infected with PEDV at an MOI of
0.1 (data not shown). These results indicated that PEDV infection
triggers early strong but transient activation of ERK1/2. Interest-
ingly, new viral protein synthesis was ﬁrst evident by 12 hpi
(Fig. 1A), while the maximal phosphorylation status of ERK1/2
was also seen at this time point, suggesting that ERK1/2 activation
occurs independently of PEDV replication. These data further
allowed us to assume that ERK1/2 regulation of the PEDV replica-
tion cycle occurs at early events in virus infection, prior to the
considerable protein production obvious at late time points. To
demonstrate this hypothesis, Vero cells were treated with an equal
amount of UV-irradiated inactivated virus that is capable of
allowing viral attachment and internalization, but incapable of
pursuing viral gene expression (Fig. 1B). UV-inactivated PEDV
efﬁciently induced ERK1/2 activation which was comparable to
the phosphorylation pattern observed in PEDV-infected cells
(Fig. 1B). Therefore, inactivated PEDV infection was found to be
still sufﬁcient to activate the ERK signaling pathway, suggesting
that initial entry events in the virus life cycle may be responsible
for early ERK activation.
Next, we tried to further conﬁrm the levels of ERK1/2 phos-
phorylation in cells infected with PEDV or treated with UV-
inactivated PEDV by using a Fast Activated Cell-Based ELISA (FACE)
assay. Consistent with the results described above, there was most
signiﬁcantly increased in the ERK1/2 phosphorylation at 12 h after
PEDV infection, showing an approximately 5-fold higher level of
phosphorylation than that in the mock-infected cells (Fig. 1C).
Moreover, the activation pattern of pEKR1/2 was virtually the
same in the UV-irradiated PEDV-exposed cells as in the non-
irradiated PEDV-infected cells (Fig. 1D). In addition, the levels of
total ERK1/2 remained unchanged in the cells infected with PEDV
and inactivated PEDV at various time points after infection when
compared to levels in mock-infected cells. Altogether, our results
demonstrated that PEDV replication was not required for ERK1/2
phosphorylation.
PEDV triggers nuclear translocalization of activated ERK1/2 and leads
to Elk-1 phosphorylation
Upon stimulation, a signiﬁcant population of ERK molecules accu-
mulates in the nucleus and activates a series of transcription factors. To
investigate how ERK1/2 activation following PEDV infection proceeds in
such a cascade, we ﬁrst examined the subcellular localization of pERK1/2
in cells infected with PEDV and UV-inactivated PEDV (Fig. 2). In mock-
infected cells, no active ERK1/2 was detected in any cellular compart-
ments during the entire period of the experiment (Fig. 2A and B, top
panels). In contrast, at 6 hpi, pERK1/2 showed distinct nuclear staining
with a weak punctuate cytoplasmic signal and was continuously
detected in the nucleus by 24 hpi (Fig. 2A). As PEDV replication
progressed, however, punctuate cytoplasmic staining of active ERK1/2
was dispersed and maintained by 24 hpi. Similarly, after exposure of
cells to UV-inactivated PEDV, the majority of pERK1/2 exhibited a
nuclear distribution with diffusely punctuate cytoplasmic staining. This
localization pattern of active ERK molecules remained unchanged by
24 h after inactivated PEDV infection (Fig. 2B). Given that Elk-1 is one of
the transcription factors phosphorylated by the ERK signaling pathway
(Shaul and Seger, 2007; Wei and Liu, 2009), we measured the activation
status of Elk-1 following PEDV-induced ERK activation (Fig. 3). No
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activation of Elk-1 was detected in mock-infected cells. In contrast, PEDV
infection resulted in the phosphorylation of Elk-1 with kinetics that
identically paralleled those observed in ERK1/2 activation (Fig. 3A).
Furthermore, cells exposed to UV-inactivated PEDV showed a phos-
phorylated Elk-1 proﬁle comparable to that in PEDV-infected cells
(Fig. 3B). This result indicated that these ERK signaling molecules that
were activated following PEDV infection cooperates in reaching their
appropriate downstream destinations to function as key regulators of
inducible cellular processes.
ERK1/2 activation regulates PEDV replication
To examine the biological importance of ERK1/2 activation in
PEDV infection, speciﬁc inhibitors of the ERK signaling pathway
were used. Vero cells were pretreated with the MEK1/2 inhibitor
U0126 or PD98050 at various concentrations or with DMSO (0.5%)
as a vehicle control for 1 h prior to infection. The inhibitor or
DMSO was present during the entire period of infection. The
cytotoxicity of the MEK inhibitors was determined by the MTT
assay in Vero cells. All doses of the inhibitors tested in the present
study caused no detectable cell death in Vero cells (data not
shown). Viral production was initially measured by monitoring the
cytopathic effect (CPE) after infection and was conﬁrmed by
immunoﬂuorescence using N protein-speciﬁc MAb at 48 hpi
(Fig. 4). In vehicle-treated control cells, visible CPE appeared at
24 hpi and became predominant by 48 hpi, and N-speciﬁc staining
was clearly evident in many cell clusters, indicating infection and
the spread of the virus to neighboring cells. In contrast, the
inhibitory effect of U0126 and PD98059 on virus propagation
was readily detectable. As shown in Fig. 4A, each inhibitor
signiﬁcantly decreased PEDV-induced CPE (ﬁrst panels) and viral
gene expression (second panels) in a dose-dependent manner. As
quantiﬁed by N protein staining results, the percentage of virus-
infected cells was similarly reduced during independent treatment
with each inhibitor, resulting in a maximal 80% inhibition at the
highest concentration used (Fig. 4B). PD98059 prevents ERK1/2
Fig. 1. PEDV activates the ERK1/2 signaling pathway in cultured cells. Vero cells were mock infected or infected with PEDV at an MOI of 1 or an equal amount of UV-
inactivated PEDV. (A and B) Whole cell lysates were prepared for the indicated times following PEDV infection (hpi) and subjected to Western blot analysis with the antibody
speciﬁc for phosphorylated ERK1/2 (pERK1/2), ERK1/2, or the PEDV N protein. The blot was also reacted with mouse MAb against β-actin to verify equal protein loading. Fold
changes in the pERK1/2:total ERK1/2 ratio are plotted. (C and D) ERK1/2 activation induced by PEDV infection was quantitatively determined using a FACE assay. Vero cells
were ﬁxed at the indicated time points with 4% formaldehyde and incubated with an anti-ERK1/2 or anti-pERK1/2 antibody followed by HRP-conjugated IgG antibodies. The
absorbance of the solution was determined at 450 nm using a spectrophotometer. These results are representative of the results of three independent experiments and error
bars represent standard deviations. n, P¼0.001 to 0.05; †, Po0.001.
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activation by blocking phosphorylation of MEK1/2, whereas U0126
is not only capable of blocking the activation of MEK1/2 but also
inhibiting MEK1/2 activity (Alessi et al., 1995; Davis et al., 2000).
Therefore, U0126 is a more potent inhibitor of ERK1/2 activation
than PD98059 (Favata et al., 1998). Our data also revealed that
U0126 was signiﬁcantly more effective in inhibiting PEDV produc-
tion (an 80% reduction in virus propagation at a concentration of
20 μM) than PD98059 (a 20% reduction in virus propagation at the
same concentration). To further show relevance, we determined
the activation status of ERK1/2, the downstream activator of
Fig. 3. Phosphorylated ERK1/2 leads to the activation of downstream target Elk-1. Vero cells were mock infected or infected with PEDV at an MOI of 1 (A) or an equal amount
of UV-inactivated PEDV (B). Whole cell lysates were prepared for the indicated times following PEDV infection (hpi) and subjected to Western blot analysis with the antibody
to pElk-1 or PEDV N. The blot was also reacted with mouse MAb against β-actin to verify equal protein loading. Fold changes in the pElk-1:β-actin ratio are plotted. These data
are representative of the results of three independent experiments and error bars represent standard deviations. †, Po0.001.
Fig. 2. PEDV induces nuclear translocation of pERK1/2. Vero cells were mock infected or infected with PEDV (A) or UV-inactivated PEDV (B). At the indicated time points,
infected cells were ﬁxed and labeled with antibodies against pERK1/2 (green) and PEDV N (red). The cells were then counterstained with DAPI, and the intracellular
localization of pERK1/2 in virus-infected cells was examined using a confocal microscope at 400 magniﬁcation.
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MEK1/2, after treatment with two MEK inhibitors in PEDV-
infected cells. Both inhibitors were found to markedly decrease
levels of pEKR1/2 at 12 hpi (Fig. 4C). However, the inhibitory effect
of the two inhibitors was inconsistent, with a signiﬁcant inhibition
observed for U0126 and PD98059 at 10 μM and 50 μM, respec-
tively. This ﬁnding indicated that the effect of both inhibitors on
virus production correlates with the ability of each compound to
inhibit ERK1/2 phosphorylation. Taken together, these data
demonstrated that treating cells with each MEK inhibitor ham-
pered the activation of ERK1/2 and accordingly suppressed PEDV
propagation, suggesting that the Raf/MEK/ERK signaling pathway
plays a role in PEDV replication.
In addition, virus yield was determined during treatment with
the two MEK inhibitors to assess whether ERK activity is truly
necessary for PEDV replication. Upon infection, viral supernatants
were collected at 48 hpi and viral titers were measured. As Fig. 5A
shows, the presence of each inhibitor reduced the release of viral
progeny in a dose-dependent manner. The peak viral titer was
determined to be 106.9 PFU/ml in the vehicle-treated control. The
addition of 20 μM U0126 reduced the PEDV titer to 103.8 PFU/ml (a
3-log reduction compared to that in the control). PD98059 slightly
reduced the virus titer at the same concentration, and the
comparable inhibitory effect on the virus titer was observed for
PD98059 at 100 μM. The growth kinetics study further demon-
strated that the overall process of PEDV replication was markedly
delayed when cells were treated with either U0126 or PD98059 at
their optimal respective concentrations (Fig. 5B). Consequently,
these ﬁndings revealed that ERK1/2 activation is required for
successful PEDV replication in cells.
To provide direct evidence for the involvement of the ERK
cascades in the regulation of PEDV, Vero cells were transfected with
small interfering RNA (siRNA) speciﬁc to ERK1/2 or a commercial
control nonspeciﬁc siRNA as a negative control. At 24 h post-
transfection, cells were infected with PEDV for 24 h and used to
determine the amounts of ERK1/2 proteins and virus propagation
(Fig. 6). The expression levels of ERK molecules were reduced by
more than 60% after siRNA treatment compared to those untreated
and treated with the control siRNA, indicating speciﬁc knockdown of
Fig. 4. PEDV propagation is suppressed by inhibition of ERK1/2 activation. (A) Vero cells were preincubated with DMSO, U0126 (5, 10, and 20 μM), or PD98059 (20, 50, and
100 μM) for 1 h prior to infection and were mock-infected or infected with PEDV at an MOI of 1. Virus-infected cells were further maintained for 48 h in the presence of
DMSO or inhibitors. PEDV-speciﬁc CPEs were observed daily and were photographed at 48 hpi using an inverted microscope at a magniﬁcation of 100 (ﬁrst panels). For
immunostaining, infected cells were ﬁxed at 48 hpi and incubated with MAb against the N protein, followed by Alexa green-conjugated goat anti-mouse secondary antibody
(second panels). The cells were then counterstained with DAPI (third panels) and examined using a ﬂuorescent microscope at 200 magniﬁcation. (B) Viral production in
the presence of each inhibitor was measured by quantifying the percentage of cells expressing N proteins through ﬂow cytometry. Values shown are representative of three
independent experiments and error bars represent standard deviations. (C) Chemical inhibition of ERK1/2 activation was quantitatively determined using FACE assay. Vero
cells were mock-infected or PEDV-infected in the presence of DMSO, U0126 (10 and 20 μM), or PD98059 (50 and 100 μM). The cells were ﬁxed at 12 hpi with 4%
formaldehyde and incubated with an anti-ERK1/2 or anti-pERK1/2 antibody followed by HRP-conjugated IgG antibodies. The absorbance of the solution was determined at
450 nm using a spectrophotometer. These results represent the results of three independent experiments and error bars represent standard deviations. *, P¼0.001 to 0.05; †,
Po0.001.
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ERK1/2 by siRNA (Fig. 6A). Furthermore, transfection of cells with
ERK1/2-speciﬁc siRNA resulted in an almost 80% decrease in the
number of PEDV-infected cells and an over 2-log reduction in virus
titer compared to the mock- or nonspeciﬁc siRNA-transfected con-
trols (B and C). The inhibitory effect of ERK1/2 siRNA on virus
production was comparable to that of the chemical inhibition. Our
data showed that knocked down expression of ERK1/2 diminishes
PEDV propagation, demonstrating an essential role of the ERK
signaling pathway in PEDV replication.
Chemical inhibition of ERK1/2 activation suppresses PEDV replication
at the early stage of infection but does not block virus internalization
To determine the point at which the two MEK inhibitors acted
during PEDV infection, Vero cells were treated independently with
each inhibitor at different time points post-infection. At 48 hpi, the
levels of PEDV replication were measured indirectly as viral
production by quantifying cells expressing the N protein through
ﬂow cytometry (Fig. 7A). Treatment of cells with 20 μM U0126 for
up to 4 hpi resulted in an 80% decrease in PEDV production when
compared to the DMSO-treated control. Addition of U0126
between 6 and 12 hpi led to a 74–45% inhibition of PEDV
infectivity. Consistently, the inhibitory proﬁle of PD98059 was
similar to that observed for U0126; however, it was less effective at
the same concentration. In contrast, little or no signiﬁcant reduc-
tion of PEDV propagation was identiﬁed when each inhibitor was
added after 24 hpi. These results demonstrated that the effects of
both inhibitors on PEDV production were exerted primarily at
early steps in the virus life cycle, suggesting the importance of the
ERK signaling pathway in the initial stage of infection.
Next, we sought to identify which step(s) of the replication
cycle of PEDV was speciﬁcally targeted by inhibition of ERK
activation. To address this issue, the earliest step, virus entry,
was initially assessed with an internalization assay upon treat-
ment with each MEK inhibitor. Vero cells were inoculated with
PEDV at 4 1C for 1 h to allow virus attachment and were further
maintained either at 4 1C or 37 1C to permit virus internalization in
the presence of U0126 (20 μM), PD98059 (100 μM), or DMSO,
followed by treatment of proteinase K to remove the remaining
viruses on the cell surface. The serially diluted infected cells were
subsequently subjected to an infectious center assay on uninfected
Vero cell monolayers, and virus titers were measured 2 days later
by plaque assay (Fig. 7B). Only minimal viral production was
observed in cells maintained at 4 1C, which was likely due to an
inefﬁcient removal of the bound virus. The viral titers were nearly
identical in cells treated with U0126, PD98059, or vehicle at 37 1C
and were determined to be 102.1, 102.2 and 102.4 PFU/ml, respec-
tively, indicating no differences among treatment of these cells.
These results indicated that neither U0126 nor PD98059 has any
inhibitory effect on the virus entry process.
Chemical inhibition of ERK1/2 activation reduces viral protein
translation and viral RNA transcription
Like other positive-sense RNA viruses, the PEDV genome is
released into the cytoplasm following the uncoating process and
immediately serves as a template for viral translation by the use of
the translation machinery of the host cell. Early PEDV translation
produces the replicase polyproteins that are proteolytically pro-
cessed into nsps. Subsequently, the nonstructural replicase pro-
teins mediate the de novo synthesis of viral RNA, including
genomic RNA replication and sg mRNA transcription. The PEDV
structural proteins are translated late in the cycle from their
respective sg mRNA transcripts. Thus, to determine the functional
mechanism of ERK1/2 regulation of PEDV infection on the post-
entry steps, we ﬁrst investigated whether viral protein translation
was affected by ERK inhibition. For this approach, Vero cells were
treated with each inhibitor for 1 h prior to infection, and then the
inhibitors were independently present during the infection and
subsequent incubation periods. The expression level of the PEDV N
protein in the presence of each inhibitor or DMSO was evaluated at
48 hpi by Western blot analysis. Each chemical inhibition had a
detrimental effect on viral protein production at different
Fig. 5. Chemical inhibition reduces viral progeny production. (A) Vero cells were
pretreated with DMSO, U0126, or PD98059 for 1 h and were mock or PEDV infected
(MOI of 1). Vehicle or each inhibitor was present in the medium throughout the
infection. At 48 hpi, the virus supernatants were collected and virus titers were
determined. (B) Growth kinetics of PEDV upon treatment with each inhibitor was
assessed exactly as for panel A. At the indicated time points postinfection, culture
supernatants were harvested and virus titers were measured. Results are expressed
as the mean values from triplicate wells and error bars represent standard
deviations. *, P¼0.001 to 0.05; †, Po0.001.
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concentrations (Fig. 8). Densitometric analysis of the Western blots
revealed that the intracellular expression of the N protein was
largely prevented by both inhibitors, and that a maximal 80%
inhibition was observed at the highest concentrations of U0126
and PD98059 used (Fig. 8). These data demonstrated the inhibitory
effect on viral protein expression due to the speciﬁc action of each
inhibitor on viral translation during PEDV replication.
Since synthesis of the viral nsps is required for viral RNA
replication and transcription, it is conceivable that the suppression
of viral protein expression could be a cascade-like result from the
inhibition of viral RNA synthesis. Because PEDV infection produces
two RNA entities, including genomic and subgenomic, we deter-
mined whether each ERK1/2 inhibitor speciﬁcally affected genome
replication and sg mRNA transcription. To answer this question,
the relative levels of both genomic RNA and sg mRNA were
assessed by quantitative real-time strand-speciﬁc RT-PCR in the
presence or absence of U0126 or PD98059 upon PEDV infection. As
shown in Fig. 9 A, both inhibitors greatly diminished viral RNA
synthesis in a dose-dependent manner, showing a maximal 90%
and 80% reduction in levels of viral genomic RNA and sg mRNA,
respectively, compared to that in the DMSO-treated infected cells,
respectively. The decrease in viral RNA levels after the addition of
each inhibitor was not due to nonspeciﬁc inhibition of transcrip-
tion, as the mRNA level of the internal GAPDH control remained
unchanged in all samples (data not shown). The impairment of
PEDV transcription in the presence of each inhibitor was further
Fig. 6. ERK1/2 knockdown suppresses PEDV infection. Vero cells were transfected with 100 nM ERK-speciﬁc siRNA or control siRNA using Lipofectamine 2000 followed by
PEDV infection at 24 h post transfection. (A) At 24 hpi, cellular lysates were prepared and subjected to immunoblotting using an antibody against the ERK protein. The blot
was also reacted with anti-β-actin antibody to verify equal protein leading. ERK protein expression was quantitatively analyzed by densitometry and presented in terms of
the relative density value to the β-actin gene, and fold changes in the total ERK:β-actin ratio are plotted. (B) PEDV-speciﬁc CPEs were observed daily and were photographed
at 24 hpi using an inverted microscope at a magniﬁcation of 200 (ﬁrst panels). For immunostaining, infected cells were ﬁxed at 24 hpi and stained with anti-PEDV N
antibody followed by Alexa green-conjugated goat anti-mouse secondary antibody (second panels). The cells were then counterstained with DAPI (third panels) and
examined using a ﬂuorescent microscope at 200 magniﬁcation. Viral production was assessed exactly as described in the legend of Fig. 4B. (C) The virus supernatants were
collected at 24 hpi and viral titers were determined. Values shown are representative of the mean of three independent experiments and error bars represent standard
deviations. †, Po0.001.
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conﬁrmed by northern blot analysis (Fig. 9B). In untreated (lane 2)
or vehicle-treated (lane 3) virus-infected cells, PEDV RNA synthesis
was distinctly observed. Consistent with real-time RT-PCR data, a
signiﬁcant reduction in RNA-synthesizing activity occurred dose-
dependently following treatment with U0126 (lanes 4 to 6) or
PD98059 (lanes 7 to 9). Taken together, these results indicated that
both ERK inhibitors speciﬁcally suppress the synthesis of the PEDV
genomic RNA and sg mRNA.
ERK1/2 activation is not involved in PEDV-induced apoptosis
The Raf/MEK/ERK signaling pathway manipulates various cell
responses including different pro-proliferative and anti-
proliferative events depending on stimuli. Growing evidence
suggests that ERK activity is associated with classical markers of
apoptosis execution, promoting apoptotic cell death in certain
conditions (Cagnol and Chambard, 2010). Interestingly, PEDV has
been shown to induce apoptosis in vitro and in vivo to facilitate
viral replication and pathogenesis (Kim and Lee, 2014). Therefore,
we speculated that the ERK pathway could play a role in the
induction of apoptosis during PEDV replication. To examine
whether ERK activation is required for PEDV-induced apoptosis,
the process of PEDV-triggered apoptosis was assessed in the
presence or absence of each ERK inhibitor using Annexin V/
propidium iodide (PI) ﬂow cytometry. Vero cells were treated
with DMSO or each compound at the indicated concentrations
followed by PEDV infection. At the indicated time points post-
infection, the treated and infected cells were stained with Annexin
V and PI and then examined using FACS ﬂow cytometry to
quantitatively determine the percentage of viable, apoptotic, and
dead cells (Fig. 10A). Neither the vehicle nor the inhibitors tested
caused signiﬁcant apoptosis under our conditions. As expected,
PEDV infection in the presence of DMSO induced a high level of
apoptosis (Annexin V positive/PI negative) appearing at 6 hpi, and
the percentage of early apoptotic cells increased with infection
time. However, chemical inhibition of ERK1/2 activation was
incapable of protecting cells from PEDV-induced apoptotic cell
death. The percentage of early apoptotic cells in treatment of cells
with either U0126 or PD98059 was comparable to that in vehicle-
treated cells during the course of infection. Moreover, with
chemical inhibition of ERK activation, nuclear translocation of
AIF, a hallmark of PEDV-induced apoptosis, was still retained
(Kim and Lee, 2014; Fig. 10B). These results indicated that the
ERK signaling pathway is not involved in PEDV-mediated apopto-
sis and its mechanism.
Discussion
The signiﬁcance of the interplay between host signaling pathways
and numerous extracellular stimuli, including viral infection, has been
extensively studied. Among these transduction signals, the ERK path-
way plays multiple pivotal roles in almost all cell functions regulating
cell fate (Cagnol and Chambard, 2010; Roux and Blenis, 2004; Shaul
and Seger, 2007). Thus, the ability of ERK1/2 to control cell cycle
progression is a reasonable target for the modulation of viral multi-
plication by acting at speciﬁc steps of the virus life cycle such as entry,
gene transcription, protein expression, and progeny release (Cai et al.,
2007; Lee and Lee, 2010; Moser and Schultz-Cherry, 2008; Planz et al.,
Fig. 7. ERK activation is required at an early stage of PEDV infection but does not affect
virus internalization. (A) Vero cells were pretreated with DMSO, U0126 (10 and 20 μM,
upper panel), or PD98059 (50 and 100 μM, lower panel) and were mock or PEDV (MOI
of 1) infected. At the indicated times post-infection, each inhibitor was added to achieve
a ﬁnal concentration. At 48 hpi, virus-infected cells were ﬁxed and virus infectivity was
determined by quantifying the percentage of cells expressing N proteins through FACS.
(B) Virus internalization assay. Vero cells were infected at an MOI of 1 at 4 1C for 1 h.
After washing with cold PBS, infected cells were maintained in the presence or absence
of each inhibitor either at 4 1C or 37 1C for an additional hour. Bound but non-
internalized virus particles were removed by treatment with proteinase K. The infected
cells were then serially diluted and plated onto Vero cells in 96-well tissue culture
plates. At 2 days post-incubation, internalized viruses were titrated by plaque assay.
Results are expressed as the mean values from triplicate wells and error bars represent
standard deviations. *, P¼0.001 to 0.05; †, Po0.001.
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2001; Pleschka et al., 2001; Wei and Liu, 2009, Wong et al., 2005).
Widespread ERK involvement appears to be a general characteristic for
optimal viral infection, which beneﬁcially functions as a global viral
strategy to enhance its own replicative machinery. Despite decades of
research, little about the intracellular signaling pathways involved in
PEDV infection and pathogenesis has been deciphered. The present
study demonstrated for the ﬁrst time that ERK activation is required for
efﬁcient PEDV replication in cultured cells. In this study, we showed
that PEDV strongly induces the activation of MAPK ERK1/2 in vitro,
suggesting a crucial role of the ERK cascade during PEDV infection.
Independent treatment with two ERK inhibitors and the knock down
of ERK1/2 greatly impaired PEDV propagation. Moreover, chemical
inhibition of ERK activation resulted in signiﬁcant attenuation of viral
replication during post-entry steps, as determined by an overall down-
regulation in viral protein expression, viral RNA synthesis, and progeny
release. Altogether, it appears that the ERK signaling pathway regulates
PEDV infection for competent viral reproduction in target cells.
As compared to infectious PEDV, the UV-inactivated virus also
efﬁciently triggered ERK activation with the analogous phosphor-
ylation kinetics, which suggested that the activation of ERK1/2
might be induced by the virus entry process, including virus-
receptor interactions and the uncoating event. Furthermore, the
productive growth of PEDV commenced at 12 hpi, as determined
by the detection of a considerable amount of the viral protein; this
corresponded to the proportionally down-regulated phosphoryla-
tion status of ERK1/2, and after 24 hpi, a reduction in the amount
of pERK1/2 below the background level. In contrast, total ERK1/2
levels were found to remain consistent in cells throughout infec-
tion with non-irradiated or UV-irradiated PEDV. Altogether, it
seems that the initial round of PEDV replication cycle, which likely
occurs within 12 hpi, is essential for the maximal activation of the
ERK signaling pathway. Interestingly, other nidoviruses have
shown similar activation proﬁles of ERK1/2 that are independent
of virus replication but are only in response to virus entry,
suggesting a unique feature of the EKR pathway in the nidovirus
biology (Cai et al., 2007; Lee and Lee, 2010). In addition, coxsack-
ievirus and astrovirus were found to mediate rapid and ephemeral
ERK activation observed within 10 to 15 min postinfection (Luo
et al., 2002; Moser and Schultz-Cherry,2008). However, in the
current study, due to the relatively slow growth rate of PEDV, we
were unable to determine how quickly the ERK pathway is
activated following infection. The one-step growth curve indicated
that the eclipse period appeared by 6 hpi and immediately after
this, progeny viruses began to be detectable. For productive
infection, PEDV particles must progressively proceed through a
multiple-step cycle consisting of entry, uncoating, genome replica-
tion and transcription, viral translation, assembly, and progeny
release. During the eclipse period, virus attachment and inter-
nalization occurs followed by uncoating to disassemble the viral
capsid for genome release, which is now ready to initiate the
replication cycle in the cytoplasm of infected cells. Although the
exact mechanism to explain ERK1/2 activation following PEDV
infection is unclear from the present study, it is tempting to
speculate that virus-receptor interactions are responsible for ERK
activation in PEDV-infected cells. The other possibility is that ERK
Fig. 9. Chemical inhibition of ERK1/2 activation interferes with viral RNA synthesis. Vero cells pretreated with DMSO, U0126, or PD98059 were mock-infected or infected
with PEDV (MOI of 1) for 1 h and were incubated in the presence of DMSO or each inhibitor. (A) Total cellular RNA was extracted at 48 hpi, and strand-speciﬁc viral genomic
RNA (black bars) and sg mRNA (white bars) were ampliﬁed by quantitative real-time RT-PCR. Viral positive-sense genomic RNA and sg mRNA were normalized to mRNA for
monkey GAPDH, and relative quantities (RQ) of mRNA accumulation were evaluated. Inhibitor-treated sample results were compared with DMSO-treated results. Values
shown are representative of the mean from three independent experiments and error bars denote standard deviations. †, Po0.001. (B) The extracted RNAwas also subjected
to northern blot analysis using the speciﬁc oligonucleotide biotin-labeled probes against the PEDV-speciﬁc 30 UTR probe. Monkey GAPDH were used as a control to correct for
variations in loading during viral RNA quantiﬁcation. The positions of the genomic RNA and sg mRNAs are indicated next to the gel.
Fig. 8. Chemical inhibition of ERK1/2 activation impairs viral protein translation.
Inhibitor-treated Vero cells were mock-infected or infected with PEDV (MOI of 1)
for 1 h and were further cultivated in the presence or absence of each inhibitor. At
48 hpi, cellular lysates were collected, resolved by SDS-PAGE, transferred to a
nitrocellulose membrane, and immunoblotted by using the antibody against the
PEDV N protein. The blot was also reacted with mouse MAb against β-actin to verify
equal protein loading. Each viral protein expression was quantitatively analyzed by
densitometry in terms of the relative density value to the β-actin gene and
inhibitor-treated sample results were compared to DMSO-control results. Values
shown are representative of the mean from three independent experiments and
error bars denote standard deviations. *, P¼0.001 to 0.05; †, Po0.001.
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cascades are stimulated by virus particles entering through direct
fusion with the cell membrane or by exposure to the disassembled
viral proteins and the released genome after the uncoating
process.
The data herein raises a question about the deﬁnite function of
activated ERK1/2 during PEDV infection. A conceivable explanation for
how ERK1/2 activation controls PEDV infection is that the ERK
pathway regulates viral replication directly or indirectly. Independent
treatment of PEDV-infected cells with each ERK inhibitor signiﬁcantly
suppressed individual postinternalizaton steps of the viral replication
process, including viral RNA synthesis, protein expression, and virus
production. Positive-sense RNA virus RdRps have been increasingly
reported to be phosphoproteins activated by host proteins, suggesting
regulation of viral RNA replication through phosphorylation of the
polymerase protein (Jakubiec and Jupin, 2007). Moreover, previous
studies have proposed that ERK1/2 activity might be necessary to
phosphorylate or stabilize the viral RdRp, which are both required for
the initiation of viral RNA replication (Luo et al., 2002; Moser and
Schultz-Cherry, 2008). Therefore, a similar phosphorylation modiﬁca-
tion may activate the PEDV RdRp (nsp12) and could be indispensable
for optimal viral RNA synthesis. ERK activation mediates apoptosis via
either intrinsic or extrinsic pathways by the induction of mitochon-
drial cytochrome c release or caspase-8 activation, respectively
(Cagnol and Chambard, 2010). Several viruses have been found to
activate the ERK pathway to modulate apoptosis for contributing to
their replication (Wong et al., 2005; Zampieri et al., 2007). We have
previously demonstrated that PEDV promotes apoptotic cell death
in vitro and in vivo to favor viral infection (Kim and Lee, 2014).
However, the current study showed a negative correlation between
the activation of ERK1/2 and apoptosis during PEDV infection. This
result was anticipated because neither caspase activation nor cyto-
chrome c release participated in the PEDV-triggered apoptosis path-
way (Kim and Lee, 2014). Alternatively, ERK1/2 activation may be
indirectly involved in PEDV infection by activating other cascades
through crosstalk or by providing a signal to the downstream cellular
transcription factors necessary for maximal virus propagation.
Furthermore, in our experimental conditions, we were unable to
completely eliminate viral replication during chemical inhibition.
Therefore, if the indirect inﬂuence of ERK1/2 activity is the case,
ERK signaling could be one of the intracellular pathways important
for PEDV replication.
In summary, our ﬁndings presented here revealed that PEDV
infection activates ERK1/2 early in infection in cultured cells and
that the activation of ERK molecules is required for efﬁcient PEDV
replication in vitro. However, viral processes or components
underlying ERK activation remain to be determined. Although
our data demonstrated the suppression of viral protein expression
as well as viral RNA transcription by inhibiting ERK activation, the
precise mechanism by which ERK activity modulates the PEDV
replication cycle during infection is still unclear and, accordingly,
this will be our next issue to address in future studies. A greater
understanding of the precise role of ERK activation in the replica-
tion of PEDV will provide new insights into the molecular biology
and pathogenesis of PEDV infection.
Material and methods
Cells, viruses, and reagents
Vero cells were cultured in alpha minimum essential medium
(α-MEM; Invitrogen, Carlsbad, CA) with 5% fetal bovine serum
(FBS; Invitrogen) and antibiotic-antimycotic solutions (100 ;
Invitrogen). The cells were maintained at 37 1C in a humidiﬁed
5% CO2 incubator. PEDV strain SM98-1 was kindly provided by the
Korean Animal and Plant Quarantine Agency and propagated in
Vero cells as described previously (Hofmann and Wyler, 1988;
Nam and Lee, 2010). Inactivation of PEDV was performed by UV
irradiation of the virus suspension with 1000 mJ/cm2 using a UV
crosslinker (Stratagene, La Jolla, CA). Virus inactivation was con-
ﬁrmed by the inoculation of the UV-treated virus on Vero cells
followed by N protein-speciﬁc staining as described below, and the
inactivated virus was stored at 80 1C. The PEDV N protein-
speciﬁc monoclonal antibody (MAb) was obtained from ChoogAng
Vaccine Laboratory (CAVAC; Daejeon, South Korea). Antibodies
speciﬁc for AIF and β-actin were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). The MEK1/2 inhibitors U0126
and PD98059, antibodies against ERK1/2, phosphorylated ERK1/2
Fig. 10. Inhibition of ERK1/2 activation does not affect PEDV-induced apoptosis. Vero cells were treated with DMSO, U0126 (20 μM), or PD98059 (100 μM) for 1 h prior to
infection and then mock-infected or infected with PEDV (MOI of 1) in the presence of DMSO or each inhibitor. (A) Cells were harvested at the indicated time points, dually
labeled with Annexin V and PI, and subjected to FACS analysis. The graph represents the percentage of each quadrant, and the non-signiﬁcant percentages of Annexin
V-negative and PI-positive cells were excluded. (B) The treated and infected cells were also labeled with MitoTracker Red CMSRos (Red), ﬁxed, and incubated with an anti-AIF
antibody (green). AIF nuclear translocation is represented by the merged AIF and DAPI signals (turquoise), and residual mitochondrial colocalization is indicated by the
merged AIF and mitochondrial marker (yellow). The inset images are enlarged versions of parts of the picture.
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(pERK1/2), phosphorylated Elk-1 (pElk-1), and ERK-speciﬁc and
unconjugated control siRNAs were obtained from Cell Signaling
Technology (Danvers, MA).
Cell viability assay
The cytotoxic effects of reagents on Vero cells were analyzed using a
colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) assay (Sigma, St Louis, MO) to detect cell viability. Brieﬂy,
Vero cells were grown at 1104 cells/well in a 96-well tissue culture
plate with PD98059 or U0126 treatment for 24 h. After 1 day of
incubation, 50 μl of MTT solution (1.1 mg/ml) was added to each well,
and the samples were incubated for an additional 4 h. The supernatant
was then removed from each well, after which 150 μl of DMSO was
added to dissolve the colored formazan crystals produced by the MTT.
The absorbance of the solution was measured at 540 nm using an
enzyme-linked immunosorbent assay plate reader. All MTTassays were
performed in triplicate.
Western blot analysis
Vero cells were grown in 6-well tissue culture plates for 1 day and
were mock infected or infected with PEDV at a multiplicity of
infection (MOI) of 1 or with an equal amount of UV-inactivated virus.
At the indicated times, cells were harvested in 50 μl of lysis buffer
(0.5% TritonX-100, 60 mM β-glycerophosphate, 15 mM ρ-nitro phenyl
phosphate, 25 mM MOPS, 15 mM, MgCl2, 80 mM NaCl, 15 mM EGTA
[pH 7.4], 1 mM sodium orthovanadate, 1 μg/ml E64, 2 μg/ml aproti-
nin, 1 μg/ml leupeptin, and 1 mM PMSF) and sonicated on ice 5 times
for 1 s each. Homogenates were lysed for 30 min on ice, and clariﬁed
by centrifugation at 15,800 g (Eppendorf centrifuge 5415R, Ham-
burg, Germany) for 30 min at 4 1C. To examine the effect of ERK
inhibition on PEDV replication, cells were pretreated independently
with each MEK inhibitor for 1 h and then infected with PEDV at an
MOI of 1. The virus-inoculated cells were further propagated in the
presence of U0126 (5–20 μM), PD98059 (20–100 μM), or DMSO
(0.5%; vehicle control) and cell lysates were prepared with lysis buffer
at 48 h hpi. The total protein concentrations in the supernatants were
determined using a BCA protein assay (Pierce, Rockford, IL). Equal
amounts of total protein were separated on a NuPAGE 4–12% gradient
Bis-Tris gel (Invitrogen) under reducing conditions and electrotrans-
ferred onto an Immobilon-P (Millipore, Bedford, MA). The membranes
were subsequently blocked with 3% powdered skim milk (BD
Biosciences, Bedford, MA) in TBS (10 mM Tris–HCl [pH 8.0], 150 mM
NaCl) with 0.05% Tween-20 (TBST) at 4 1C for 2 h and incubated at
4 1C overnight with the primary antibody against pERK1/2, ERK1/2,
pElk-1, PEDV N, or β-actin. The blots were then incubated with the
corresponding secondary HRP-labeled antibodies at a dilution of
1:5000 for 2 h at 4 1C. Proteins were visualized using enhanced
chemiluminescence (ECL) reagents (GE Healthcare, Piscataway, NJ)
according to the manufacturer’s instructions. Ratios of phosphory-
lated/total ERK1/2 and phosphorylated Elk-1/β-actin were compared
by densitometry of the corresponding bands using a computer
densitometer with the Wright Cell Imaging Facility (WCIF) version
of the ImageJ software package (http://www.uhnresearch.ca/facilities/
wcif/imagej/). To quantify viral protein production, the band densities
of PEDV N proteins were quantitatively analyzed using a computer
densitometer with ImageJ software in terms of the density value
relative to that of the β-actin gene.
Fast activated cell-based ELISA (FACE)
FACE kit was obtained from Active Motif (Carlsbad, CA) and was
used to determine the levels of ERK1/2 MAPK activation according
to the manufacturer’s protocols. Brieﬂy, Vero cells seeded in 96-
well tissue culture plate were grown for 1 day and were infected
with PEDV or UV-inactivated virus as described above. At the
indicated times, infected cells were ﬁxed with 4% formaldehyde. In
addition, Vero cells were pretreated independently with each MEK
inhibitor for 1 h followed by PEDV infection and ﬁxed at 12 hpi.
After washing and blocking, cells were reacted overnight with an
anti-ERK1/2 or anti-phospho-ERK1/2 antibody. Following incuba-
tion with an HRP-conjugated secondary antibody, a colorimetric
analysis was performed, with the absorbance of the solution
determined at 450 nm using a spectrophotometer.
Immunoﬂuorescence assay (IFA)
Vero cells grown on microscope coverslips placed in 6-well
tissue culture plates were mock infected or infected with PEDV or
UV-inactivated PEDV at an MOI of 1 for the indicated times. To
assess the effect of MEK inhibitors on PEDV infection, cells were
pretreated with U0126, PD98059, or DMSO for 1 h and then
infected with PEDV. Virus-infected cells were subsequently main-
tained in the presence of vehicle or each inhibitor for 48 h. All
treated cells were ﬁxed with 4% paraformaldehyde for 10 min at
RT and permeabilized with 0.2% Triton X-100 in PBS at RT for
10 min. The cells were blocked with 1% bovine serum albumin
(BSA) in PBS for 30 min at RT and then incubated with pERK1/2 or
PEDV N-speciﬁc MAb for 2 h. After being washed ﬁve times in PBS,
the cells were incubated for 1 h at RT with a goat anti-mouse
secondary antibody conjugated to Alexa Fluor 488 (Invitrogen),
followed by counterstaining with 40,6-diamidino-2-phenylindole
(DAPI; Sigma). The coverslips were mounted on microscope glass
slides in mounting buffer and cell staining was visualized using a
ﬂuorescent Leica DM IL LED microscope (Leica, Wetzlar, Germany).
To examine AIF subcellular localization under the chemical inhibi-
tion of PEDV-induced ERK activation, MitoTracker Red CMXRos
(200 nM; Invitrogen) was added to vehicle or MEK inhibitor-
treated and virus-infected Vero cells and left for 45 min at 37 1C
prior to ﬁxation. The cells were then stained with AIF-speciﬁc
antibody as described above, and cell staining was analyzed using
a Confocal Laser Scanning microscope (Carl Zeiss, Gattingen,
Germany).
Fluorescence-activated cell sorting (FACS) analysis
Quantiﬁcation of PEDV-infected cells upon independent treat-
ment of each MEK inhibitor was analyzed by ﬂow cytometry. Vero
cells were pretreated with U0126, PD98059, or DMSO for 1 h,
infected with PEDV, and subsequently maintained in the presence
of vehicle or each inhibitor. Virus-infected cells were trypsinized at
48 hpi and centrifuged at 250 g (Hanil Centrifuge FLETA 5) for
5 min. The cell pellet was washed with cold washing buffer (1%
BSA and 0.1% sodium azide in PBS), and 106 cells were resus-
pended in 1% formaldehyde solution in cold wash buffer for
ﬁxation at 4 1C in the dark for 30 min followed by centrifugation
and incubation of the pellet in 0.2% Triton X-100 in PBS at 37 1C for
15 min for permeabilization. After centrifugation, the cell pellet
was resuspended in a solution of the primary anti-N MAb and the
mixture was incubated at 4 1C for 30 min. The cells were washed
and allowed to react with an Alexa Fluor 488-conjugated anti-
mouse IgG secondary antibody at 4 1C for 30 min in the dark. The
stained cells were washed again and analyzed on a FACSAria III
ﬂow cytometer (BD Biosciences).
Time course of MEK1/2 inhibitor treatment
Vero cells were infected with PEDV, at an MOI of 1. At –1, 0, 1, 2,
4, 6, 8, 10, 12, or 24 hpi, inhibitors were added to give the indicated
ﬁnal concentration over the remainder of the time course experi-
ment. The PEDV-infected and inhibitor-treated cells were further
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maintained and the infection was terminated at 48 hpi by ﬁxing
the monolayers with 4% paraformaldehyde for 10 min at RT. The
ﬁxed cells were subjected to FACS analysis to assess the presence
of PEDV infection as described above.
Virus titration
Vero cells were PEDV infected and treated with U0126,
PD98059, or DMSO. The culture supernatants were collected at
different time points (6, 12, 24, 36, and 48 hpi) and stored at
80 1C. The PEDV titer was determined by plaque assay using
Vero cells as described previously (Nam and Lee, 2010) and
quantiﬁed as plaque-forming units (PFU) per ml.
Virus internalization assay
An internalization assay was performed as described previously
with some modiﬁcations (Cai et al., 2007). Brieﬂy, Vero cells grown
in 6-well culture plate were pretreated and infected with PEDV at
an MOI of 1 at 4 1C for 1 h in the presence of respective
compounds. Unbound viruses were then washed with PBS, and
the cells were either incubated at 4 1C or 37 1C in the presence of
each MEK1/2 inhibitor or DMSO for 1 h, followed by treatment
with proteinase K (0.5 mg/ml) at 4 1C for 45 min to remove the
bound but uninternalized virus particles. The PEDV-infected cells
were then serially diluted in culture medium and added onto fresh
Vero cell monolayers in 96-well tissue culture plates. At 48 h post-
incubation, internalized viruses were titrated using plaque assay
and quantiﬁed as PFU per ml.
Quantitative real-time RT-PCR
Vero cells were incubated with each MEK1/2 inhibitor or DMSO
for 1 h prior to infection and then inoculated with PEDV at an MOI
of 1 for 1 h at 37 1C. The virus inoculum was subsequently
removed and the infected cells were maintained in fresh medium
containing U0126, PD98059, or DMSO for 48 h. Total RNA was
extracted from lysates of the infected cells at 48 hpi using TRIzol
reagent (Invitrogen) and treated with DNase I (TaKaRa, Otsu,
Japan) according to the manufacturer’s instructions. The concen-
trations of the extracted RNA were measured using a NanoVue
spectrophotometer (GE Healthcare). Quantitative real-time RT-PCR
was conducted using a Thermal Cycler Dice Real Time System
(TaKaRa) with gene-speciﬁc primer sets described previously (Kim
and Lee, 2013). The RNA levels of viral genes were normalized to
that of mRNA for the glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) gene, and relative quantities (RQ) of mRNA accumulation
were evaluated using the 2ΔΔCt method. To detect alterations in
the genomic RNA and sg mRNA levels in the presence of each
MEK1/2 inhibitor during PEDV infection, the results obtained using
inhibitor-treated samples were compared to those of DMSO-
treated results.
Northern blotting
Vero cells were pretreated with each inhibitor for 1 h followed
by PEDV inoculation and were maintained as described above.
Total RNA was extracted from lysates of the infected cells at 48 hpi
using TRIzol reagent and treated with DNase I. Northern blotting
was conducted by the NorthernMax Kit (Ambion, Austin, TX)
according to the manufacturer’s instructions. Samples of total
RNA (5 μg) were loaded and separated by electrophoresis through
Denaturing Gel Buffer-containing 1% agarose gel. The separated
total RNA was then transferred to a BrightStar-Plus nylon mem-
brane (Ambion) for 3 h and cross-linked by UV light for 5 min. Pre-
hybridization was performed at 42 1C for 40 min followed by
detection using the PEDV-speciﬁc 30 UTR probe (50-GCGGATCTT-
TAATTACTCGTGCAAAGGTTTAGATGAAAAGGTACTGCGTTCCCC-30)
or monkey glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
(50-GCCTGGCTGTTAGGTATCGGTGAGG-30). The blot was hybridized
to biotin-labeled oligonucleotide probes in ULTRAhyb reagent at
42 1C overnight and washed twice with low-stringency blocking
buffer and wash buffer. Target viral RNAs were detected by the
BrightStar BioDetect Kit (Ambion) according to the manufacturer’s
protocols. The membrane was incubated with alkaline
phosphatase-conjugated streptavidin followed by reaction with
the chemiluminescent substrate CDP-STAR (Ambion). The overlaid
ﬁlms were obtained by exposure in a dark cassette box in a
dark room.
Knocked down expression of ERK by siRNA
Vero cells were transfected with 100 nM siRNA targeting ERK1/2
or control siRNA using Lipofectamin 2000 (Invitrogen) according to
the manufacturer’s protocols. At 24 h post transfection, cells were
infected with PEDV at an MOI of 1 for 24 h. ERK1/2 proteins were
detected by Western blot analysis and quantitatively analyzed using
a computer densitometer as described above. At 24 hpi, the infected
cells were ﬁxed and subjected to PEDV N-speciﬁc IFA, while the
culture supernatants were harvested and subjected to virus titration
by plaque assay.
Annexin V and PI staining assay
Vero cells were pretreated with each inhibitor for 1 h and then
mock infected or infected with PEDV at an MOI of 1. The virus-
inoculated cells were further propagated in the presence of U0126
(20 μM), PD98059 (100 μM), or DMSO. Phosphatidylserine expo-
sure was determined by measuring Annexin V binding at the
indicated times using an Alexa Fluor 488 Annexin V/Dead Cell
Apoptosis Kit (Invitrogen), according to the manufacturer's proto-
col. In brief, cells were harvested, washed with cold PBS, and
suspended in 100 μl 1 annexin-binding buffer. The cells were
then incubated with Alexa Fluor 488-conjugated Annexin V and PI
at RT for 15 min in the dark. Following the incubation period,
400 μl of annexin-binding buffer was added to each sample, and
the samples were mixed gently and kept on ice. The ﬂuorescent
signals of Annexin V and PI were detected at channels FL-1 and FL-
2, respectively, and analyzed using a FACSAria III ﬂow cytometer.
Cells negative for PI uptake and positive for Annexin V were
considered apoptotic.
Statistical analysis
All statistical analyses were performed using Student’s t-test,
and P-values of less than 0.05 were considered statistically
signiﬁcant.
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